AKBLF
Price
$30.44
Change
-$0.08 (-0.26%)
Updated
Jul 22 closing price
Capitalization
6.9B
MNPR
Price
$44.97
Change
-$1.85 (-3.95%)
Updated
Jul 25 closing price
Capitalization
275M
Interact to see
Advertisement

AKBLF vs MNPR

Header iconAKBLF vs MNPR Comparison
Open Charts AKBLF vs MNPRBanner chart's image
Alk Abello AS
Price$30.44
Change-$0.08 (-0.26%)
Volume$28
Capitalization6.9B
Monopar Therapeutics
Price$44.97
Change-$1.85 (-3.95%)
Volume$10.25K
Capitalization275M
AKBLF vs MNPR Comparison Chart in %
Loading...
AKBLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKBLF vs. MNPR commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKBLF is a Hold and MNPR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (AKBLF: $30.44 vs. MNPR: $44.97)
Brand notoriety: AKBLF and MNPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKBLF: 347% vs. MNPR: 23%
Market capitalization -- AKBLF: $6.9B vs. MNPR: $275M
AKBLF [@Biotechnology] is valued at $6.9B. MNPR’s [@Biotechnology] market capitalization is $275M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKBLF’s FA Score shows that 0 FA rating(s) are green whileMNPR’s FA Score has 0 green FA rating(s).

  • AKBLF’s FA Score: 0 green, 5 red.
  • MNPR’s FA Score: 0 green, 5 red.
According to our system of comparison, AKBLF is a better buy in the long-term than MNPR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKBLF’s TA Score shows that 1 TA indicator(s) are bullish while MNPR’s TA Score has 6 bullish TA indicator(s).

  • AKBLF’s TA Score: 1 bullish, 3 bearish.
  • MNPR’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, MNPR is a better buy in the short-term than AKBLF.

Price Growth

AKBLF (@Biotechnology) experienced а -0.28% price change this week, while MNPR (@Biotechnology) price change was -3.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

MNPR is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKBLF($6.9B) has a higher market cap than MNPR($275M). MNPR YTD gains are higher at: 104.409 vs. AKBLF (36.197). AKBLF has higher annual earnings (EBITDA): 1.55B vs. MNPR (-17.66M). AKBLF has more cash in the bank: 517M vs. MNPR (54.6M). MNPR has less debt than AKBLF: MNPR (0) vs AKBLF (800M). AKBLF has higher revenues than MNPR: AKBLF (5.71B) vs MNPR (0).
AKBLFMNPRAKBLF / MNPR
Capitalization6.9B275M2,508%
EBITDA1.55B-17.66M-8,788%
Gain YTD36.197104.40935%
P/E Ratio46.17N/A-
Revenue5.71B0-
Total Cash517M54.6M947%
Total Debt800M0-
FUNDAMENTALS RATINGS
AKBLF: Fundamental Ratings
AKBLF
OUTLOOK RATING
1..100
94
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
41
SMR RATING
1..100
49
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
80
SEASONALITY SCORE
1..100
45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKBLFMNPR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
36%
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
38%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
30%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
36%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
33%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
36%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
AKBLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VCUFF0.11N/A
+4.38%
Vizsla Copper Corp.
PINXF0.70N/A
N/A
Peoples Insurance Company Group China
YHEKF1.94N/A
N/A
YEAHKA LTD.
NPTVF21.76N/A
N/A
Nippon Television Network Corporation
UNIB15.90N/A
N/A
University Bancorp, Inc.

AKBLF and

Correlation & Price change

A.I.dvisor tells us that AKBLF and MNPR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKBLF and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKBLF
1D Price
Change %
AKBLF100%
N/A
MNPR - AKBLF
29%
Poorly correlated
-3.95%
MSCLF - AKBLF
27%
Poorly correlated
-1.69%
IOVA - AKBLF
26%
Poorly correlated
-4.86%
SMMT - AKBLF
25%
Poorly correlated
+3.99%
VBIZF - AKBLF
24%
Poorly correlated
N/A
More

MNPR and

Correlation & Price change

A.I.dvisor tells us that MNPR and QNCX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MNPR and QNCX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNPR
1D Price
Change %
MNPR100%
-3.95%
QNCX - MNPR
32%
Poorly correlated
-0.54%
AKBLF - MNPR
29%
Poorly correlated
N/A
CVKD - MNPR
29%
Poorly correlated
+0.70%
BDRX - MNPR
26%
Poorly correlated
-0.28%
VKTX - MNPR
26%
Poorly correlated
+2.75%
More